We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




iPad System Programs Implanted Pacemaker Devices

By HospiMedica International staff writers
Posted on 28 May 2019
Print article
Image: The CareLink SmartSync, with base station, telemetry head and iPad controller (Photo courtesy of Medtronic).
Image: The CareLink SmartSync, with base station, telemetry head and iPad controller (Photo courtesy of Medtronic).
A tablet-based management system provides portable and secure wireless programming of implanted cardiac devices (ICDs).

The Medtronic (Dublin, Ireland) CareLink SmartSync device manager is a next-generation programmer and pacing system analyzer that features a simplified user interface, enhanced security, and Bluetooth capabilities to communicate with compatible Medtronic BlueSync devices. The portable, wireless system allows physicians more freedom to engage with patients as they program and manage cardiac devices and device data. The SmartSync system includes the CareLink SmartSync mobile application, a patient connector (telemetry head), and a base station (pacing system analyzer).

SmartSync also includes the MyCareLink Heart mobile app, which allows patients to communicate with compatible BlueSync-enabled cardiac devices. In terms of security, the SmartSync device manager, similar to all of Medtronic’s BlueSync-enabled heart devices, comes with multi-encryption protocols, run-time application monitoring for intrusion detection security controls, and access restrictions to the device and data. BlueSync enabled Medtronic pacemakers include the Azure and Percepta pacemakers, and the Serena and Solara quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps).

“Medtronic is committed to developing smart technology solutions that help physicians seamlessly provide high-quality care to cardiac patients,” said Rob Kowal, MD, PhD, chief medical officer of the Cardiac Rhythm and Heart Failure division at Medtronic. “SmartSync is another important innovation reinforcing that commitment. Clinicians will benefit from the portability that SmartSync offers, and because it was built to replicate the familiar CareLink 2090 interface, the transition to this new technology is quite simple.”

“The wireless capabilities and data transfer options of the SmartSync Device Manager have increased my efficiency in the lab and allow me to interact with my patients and peers more directly without sacrificing performance,” said consultant cardiologist Klaus Witte, MD, FRCP, lead clinician for cardiology at the University of Leeds (United Kingdom) and Leeds Teaching Hospitals NHS Trust (United Kingdom). “This type of portable device programing represents the future of cardiac data technology.”

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Patient Warming Blanket
Patient Warming Blanket
New
Portable Ventilator
Oxivent Life

Print article

Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.